Cognistar 60 Injection is used in some settings as an adjunctive treatment for neurological conditions such as stroke or brain injury. It is a single-ingredient medicine containing cerebroprotein hydrolysate, a mixture of low-molecular-weight peptides.
Evidence and clinical benefit vary by condition, and this injection is not a substitute for established treatment. It is given by injection under medical supervision, with the dose and duration decided by your doctor based on your condition.
Following your rehabilitation and physiotherapy plan alongside this medicine can support recovery.
Tell your doctor about any allergies or other medicines before treatment. Report any agitation, confusion or unusual behaviour promptly. Do not stop this treatment unless your doctor advises you to do so.






























































